Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases

This study will be a retrospective, registry study collecting data of patients who were diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from patient's chart retrospectively once the patients have completed proper treatment follow up with physicians' practice.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Gastrointestinal Disease Digestive System Diseases Gastrointestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Methodist Richardson Medical Center

Richardson, Texas, 75082, United States

About this study

It is reported in the literature that the treatment of any gastrointestinal disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with gastrointestinal cancer continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. The goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity.

The main aim of this study is to evaluate and compare the outcomes from our treatment of benign or malignant gastrointestinal diseases through medical chart review.

There is a need to understand and improve the current diagnosis and treatment algorithm for gastrointestinal pathologies. Continued evaluation and study is imperative to ensure that national guidelines are improving to enhance patient cure and/or recovery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients diagnosed and treated for gastrointestinal diseases, benign or malignant from 2005 to 2030.
Age ≥18 years

Exclusion criteria

Patients that are not diagnosed with or treated for gastrointestinal diseases
Age <18 years

Treatment and study plan

Primary outcomes

Overall survival

Time frame: Jan 2005 - Jan 2030

from day of diagnosis or procedure to death date
Overall symptom

Time frame: Jan 2005 - Jan 2030

Difficulty swallowing, Heartburn, Regurgitation, Chest pain, Weight Loss, Quality of life
Mortality

Time frame: Jan 2005 - Jan 2030

death or life
Morbidity

Time frame: Jan 2005 - Jan 2030

yes or no to individual disease

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2030
Study completion: 2030
First posted: Nov 10, 2021
Registry last updated: Apr 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation